Therefore, it is similar in principle to the approved CAR T-cell therapies used in cancer therapy, such as Kymriah and ...

All of the drugs are being positioned as off-the-shelf alternatives to CAR-T cell therapies for NHL, such as Gilead Sciences' Yescarta (axicabtagene ciloleucel), Novartis' Kymriah ...

In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a ...

Mizuho Securities analyst Salim Syed has assigned their bullish stance on GILD stock, giving a Buy rating yesterday.Pick the best stocks and ...

The inMIND trial results have elevated expectations for Monjuvi's commercial success, but competition is on the horizon.

Christopher Wray Will Step Down as F.B.I. Director President-elect Trump had already signaled his intention to replace Mr. Wray with a longtime loyalist, Kash Patel. U.S. Colleges Warn Foreign ...

December 12, 2024 • In 2012, Karam Shaar had to leave his home country of Syria due to the civil war. But he still wanted to make a difference. Through his economic analysis, he uncovered ...

Canada Post, union still at odds as strike nears 1 month Canada Post, union still at odds as strike nears 1 month Canada Post says the latest offer from the union representing its striking workers ...

European Space Agency launches Proba-3 to create an artificial solar eclipse and study the sun’s atmosphere, the corona.

Gilead subsidiary Kite has been a pioneer in the autologous CAR T-cell therapy space. The drugmaker markets Yescarta ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...